Skip to content

Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?

Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03350763
Enrollment
0
Registered
2017-11-22
Start date
2017-11-18
Completion date
2025-12-31
Last updated
2021-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

Pancreatic Cancer, Biliary decompression

Brief summary

This study looks in to the rate of biliary stent dysfunction for plastic and metallic stents in patients who need biliary drainage due to a tumor in pancreas before possible pancreaticoduodenectomy. Complications related to the biliary decompression, and possible post-surgical complications in all patients are also recorded. This trial aims to confirm whether metallic biliary stents really are superior to plastic stents as some previous studies suggest. Specific patient groups are also evaluated individually to see, whether patients with ongoing cholangitis at the time of diagnosis or patients receiving neoadjuvant treatments have less stent dysfunction cases and complications with metallic stents than with plastic stents.

Interventions

DEVICETannenbaum 10 Fr biliary stent

Tannenbaum 10 Fr biliary stent

DEVICESelf-expandable metallic biliary stent

ie WallFlex biliary RX

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Resectable tumor of the head of the pancreas * Elevated serum bilirubin levels * Radiologically visible dilatation of the biliary system

Exclusion criteria

* Distant metastasis * Inoperable tumor or other reason, why the patient is unfit for surgery

Design outcomes

Primary

MeasureTime frame
Stent failure rate, and need for re-procedure before pancreaticoduodenectomy.Evaluation at the day of pancreatic surgery

Secondary

MeasureTime frame
Other complications related to preoperative biliary decompression, and post-surgical complicationsComplication emerged within 120 days from pancreaticoduodenectomy

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026